NasdaqGM - Nasdaq Real Time Price USD

Summit Therapeutics Inc. (SMMT)

Compare
20.09 -0.50 (-2.43%)
As of 10:24 AM EDT. Market Open.
Currency in USD All numbers in thousands
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
--
--
705.00
1,809.00
860.00
Operating Expense
143,736.00
88,770.00
64,283.00
87,984.00
53,162.00
Operating Income
-143,736.00
-88,770.00
-63,578.00
-86,175.00
-52,302.00
Net Non Operating Interest Income Expense
-1,439.00
-6,058.00
-2,888.00
-242.00
-251.00
Other Income Expense
-16,553.00
-520,135.00
-12,273.00
-2,174.00
-325.00
Pretax Income
-161,693.00
-614,928.00
-78,782.00
-88,602.00
-52,910.00
Tax Provision
--
--
--
--
-213.00
Net Income Common Stockholders
-161,693.00
-614,928.00
-78,782.00
-88,602.00
-52,697.00
Diluted NI Available to Com Stockholders
-161,693.00
-614,928.00
-78,782.00
-88,602.00
-52,697.00
Basic EPS
-0.11
-0.99
-0.41
-0.96
-0.76
Diluted EPS
-0.11
-0.99
-0.41
-0.96
-0.76
Basic Average Shares
702,664.99
619,646.18
193,336.06
92,293.75
69,338.16
Diluted Average Shares
702,664.99
619,646.18
193,336.06
92,293.75
69,338.16
Total Operating Income as Reported
-158,708.00
-609,650.00
-72,089.00
-86,186.00
-53,193.00
Total Expenses
143,736.00
88,770.00
64,283.00
87,984.00
53,162.00
Net Income from Continuing & Discontinued Operation
-161,693.00
-614,928.00
-78,782.00
-88,602.00
-52,697.00
Normalized Income
-145,308.00
-95,045.00
-66,205.00
-86,467.00
-51,895.24
Interest Income
--
10,403.00
1,513.00
--
4.00
Interest Expense
11,842.00
16,461.00
4,401.00
242.00
255.00
Net Interest Income
-1,439.00
-6,058.00
-2,888.00
-242.00
-251.00
EBIT
-149,851.00
-598,467.00
-74,381.00
-88,360.00
-52,655.00
EBITDA
-147,890.00
-596,417.00
-71,867.00
-85,905.00
-50,652.00
Reconciled Depreciation
1,961.00
2,050.00
2,514.00
2,455.00
2,003.00
Net Income from Continuing Operation Net Minority Interest
-161,693.00
-614,928.00
-78,782.00
-88,602.00
-52,697.00
Total Unusual Items Excluding Goodwill
-16,385.00
-519,883.00
-12,577.00
-2,135.00
-805.00
Total Unusual Items
-16,385.00
-519,883.00
-12,577.00
-2,135.00
-805.00
Normalized EBITDA
-131,505.00
-76,534.00
-59,290.00
-83,770.00
-49,847.00
Tax Rate for Calcs
--
--
--
--
0.00
Tax Effect of Unusual Items
--
--
--
--
-3.24
12/31/2020 - 3/5/2015

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers